This article provides an overview of the key risks that can be associated with the use of secondary reference standards (RS) and illustrates scientific challenges associated with transitioning from pharmacopeial RS to secondary RS.
Christian Zeine
Advertisement
Articles by Christian Zeine
Advertisement
Latest Updated Articles
The Value of Pharmacopeial Reference StandardsPublished: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
